USDA Considers Groundbreaking Poultry Vaccination Plan
The USDA is considering vaccinating poultry against bird flu, potentially influencing exports while causing significant debate. Additionally, the EU is set to approve Madrigal's liver disease drug, marking a pivotal shift in treatment. Meanwhile, Eli Lilly prepares to release obesity drug results expected in the third quarter.
The U.S. Department of Agriculture is assessing a remarkable plan to vaccinate poultry against bird flu, a first for the nation, potentially impacting export markets. This moves forward as proposals from egg and turkey producer associations necessitate action following a devastating virus outbreak.
In Europe, Madrigal Pharmaceuticals' new liver disease drug, Rezdiffra, has received conditional backing for usage, poised to be the leading treatment for specific fatty liver conditions. This follows its initial approval in the United States last year, filling a significant treatment void in the EU.
Globally, the World Organisation for Animal Health declared a bird flu outbreak on a Brazilian farm resolved, reinforcing Brazil's status as free from the virus in commercial flocks. Meanwhile, Eli Lilly reveals promising results regarding its obesity treatment drug, with expectations laid for pivotal third-quarter disclosures.
(With inputs from agencies.)
- READ MORE ON:
- USDA
- bird flu
- vaccination
- poultry
- Madrigal
- Rezdiffra
- Eli Lilly
- obesity
- drug development
- liver disease
Google News